Your Company's Response to Coronavirus
As cases of coronavirus (COVID-19) continue to increase around the world, this resource center is designed to keep you informed on key information to keep your employees safe and business operating. This information will be regularly updated, check back often.
The U.S. Small Business Administration offers guidance for small businesses to keep employees, customers, and themselves healthy during COVID-19.
Bill & Melinda Gates Foundation, Wellcome, and Mastercard have launched Therapeutics Accelerator, an initiative to speed up development and access to therapies.
CMS and ASPR released a new toolkit to help state and local healthcare decision-makers maximize workforce flexibilities when confronting COVID-19 in their communities.
DARPA publicizes funding opportunities primarily by posting Broad Agency Announcements (BAAs) that formally solicit proposals tied to program-specific areas of research and development.
In light of the emergence and spread of COVID-19 in the U.S. and abroad, NSF is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19
This DCL complements a separate National Science Foundation (NSF) DCL (NSF 20-052) that referred to the emergence of COVID-19 and expressed NSF's interest in accepting proposals to conduct non-medical, non-clinical-care research
The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services
Link to the full text of the Emergency Declaration.
Guide to assess physical, supply chain, and cybersecurity issues that may arise from the spread of novel Coronavirus (COVID-19).
The President’s Executive Order signed on May 14, 2020 provides DFC the tools under the DPA to re-shore domestic production of strategic resources needed to respond to the COVID-19 outbreak, and to strengthen any relevant domestic supply chains.
The Department of Defense has created an industry portal as a one-stop shop for defense industry, commercial companies and academia to share creative ideas with federal agencies to combat coronavirus.
EPA Guidance on registered antimicrobial products for use against novel coronavirus SARS-CoV-2, the cause of COVID-19.
Last update: Monday, January 25, 2021 @ 4:42 pm EST
Explore BIO
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved